| Hybridization of imidazole with various heterocycles in targeting cancer: a decade's work G Teli, PA Chawla ChemistrySelect 6 (19), 4803-4836, 2021 | 15 | 2021 |
| An insight into synthetic strategies and recent developments of dihydrofolate reductase inhibitors P Chawla, G Teli, RK Gill, RK Narang ChemistrySelect 6 (43), 12101-12145, 2021 | 13 | 2021 |
| Exploration of antioxidant, anti-inflammatory and anticancer potential of substituted 4-thiazolidinone derivatives: Synthesis, biological evaluation and docking studies Archna, PA Chawla, G Teli, S Pathania, S Singh, V Srivastava Polycyclic Aromatic Compounds 43 (1), 597-618, 2023 | 8 | 2023 |
| Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor … R Pal, G Teli, GSP Matada, PS Dhiwar Journal of Molecular Structure, 136021, 2023 | 6 | 2023 |
| The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis R Pal, G Teli, GSP Matada European Journal of Medicinal Chemistry, 115609, 2023 | 3 | 2023 |
| Nano-biosensors from agriculture to Nextgen diagnostic tools D Sharma, G Teli, K Gupta, G Bansal, GD Gupta, PA Chawla Current Nanomaterials 7 (2), 110-138, 2022 | 3 | 2022 |
| An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC) R Pal, G Teli, S Sengupta, L Maji, GS Purawarga Matada Journal of Biomolecular Structure and Dynamics, 1-17, 2023 | 2 | 2023 |
| Exploring the Potential of Substituted 4-Thiazolidinone Derivatives in the Treatment of Breast Cancer: Synthesis, Biological Screening and In Silico Studies G Teli, P Sharma, PA Chawla Polycyclic Aromatic Compounds 43 (7), 6202-6234, 2023 | 2 | 2023 |
| An updated literature on BRAF inhibitors (2018–2023) L Maji, G Teli, NM Raghavendra, S Sengupta, R Pal, A Ghara, ... Molecular Diversity, 1-42, 2023 | 2 | 2023 |
| Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships R Pal, G Teli, G Swamy Purawarga Matada, P Sanjay Dhiwar ChemistrySelect 8 (26), e202301200, 2023 | 2 | 2023 |
| In vitro anti-inflammatory and antioxidant activity of Nephrolepis cordifolia and molecular docking of its active chemical constituent R Pal, G Teli, B Sharma, B Kumar, PA Chawla Pharmaspire 13, 21-27, 2021 | 2 | 2021 |
| Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase G Teli, R Pal, L Maji, GS Purawarga Matada, S Sengupta Journal of Biomolecular Structure and Dynamics 42 (3), 1582-1614, 2024 | 1 | 2024 |
| Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity … G Teli, R Pal, L Maji, S Sengupta, NM Raghavendra, GSP Matada Chemistry & Biodiversity 20 (9), e202300515, 2023 | 1 | 2023 |
| Molnupiravir–A prospective silver bullet to mitigate severe acute respiratory syndrome corona virus-2 M Negi, PA Chawla, G Teli, A Faruk, V Chawla | 1 | 2021 |
| Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship L Maji, S Sengupta, GS Purawarga Matada, G Teli, G Biswas, PK Das, ... Molecular Diversity, 1-47, 2024 | | 2024 |
| Synthetic product-based approach toward potential antileishmanial drug development R Pal, G Teli, MJ Akhtar, GSP Matada European Journal of Medicinal Chemistry, 115927, 2023 | | 2023 |
| Designing Studies in Pharmaceutical and Medicinal Chemistry NM Raghavendra, BRP Kumar, P Sasmal, G Teli, R Pal, ... The Quintessence of Basic and Clinical Research and Scientific Publishing …, 2023 | | 2023 |
| Nitrogen-containing Heterocyclic Derivatives of 1, 3-Thiazolidine-2, 4-Diones as Dual Anti-inflammatory and Anti-oxidant Agents and their Docking Studies P Srivastava, G Teli, PA Chawla Letters in Drug Design & Discovery 20 (7), 894-915, 2023 | | 2023 |
| Designing Studies in Pharmaceutical 9 NM Raghavendra, BRP Kumar, P Sasmal, G Teli, R Pal, PMG Swamy, ... The Quintessence of Basic and Clinical Research and Scientific Publishing, 125, 0 | | |
